Keros Therapeutics, Inc. (KROS)
19.50
+0.62
(+3.28%)
USD |
NASDAQ |
Jan 13, 16:00
19.52
+0.02
(+0.10%)
After-Hours: 20:00
Keros Therapeutics Price: 19.50 for Jan. 13, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1077.19 |
| Pfizer Inc. | 25.15 |
| Innoviva, Inc. | 19.51 |
| Ocugen, Inc. | 1.91 |
| Bionano Genomics, Inc. | 1.58 |
Price Related Metrics
| PE Ratio | 12.64 |
| PS Ratio | 3.213 |
| Price to Book Value | 0.8444 |
| Price to Free Cash Flow | 9.102 |
| Earnings Yield | 7.91% |
| Market Cap | 594.09M |
| Operating PE Ratio | 18.19 |
| Normalized PE Ratio | 12.64 |